[No standalone website (unbranded, no questionnaire)] A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site

Study’s contact

Call center

+351 22 986 6100

Email address

diogo.magalhaes@bial.com

Condition

Parkinson Disease

Treatment type

Observational

Investigational product

Levodopa (L-DOPA) + Standard care

Sponsor

Bial - Portela C S.A.

ClinicalTrials.gov identifier

NCT03959540

Study number

BIA-91067-402

Understanding clinical trials

Get answers to your questions about clinical trials.

About the study

The purpose of this study is to describe the safety and efficacy of opicapone plus standard of care in elderly patients with PD in the real-world setting

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria
  1. Patient or legally acceptable representative willing and able to provide informed consent as mandated by local regulation
  2. Patient with clinical diagnosis of idiopathic PD (excluding non-idiopathic PD: atypical Parkinsonism, secondary [acquired or symptomatic] Parkinsonism, Parkinson-plus syndrome)
  3. Patient with age >=75 years at enrolment
  4. Patient with end-of-dose motor fluctuations suitable for additional treatment optimization
Exclusion criteria
  1. Patient concurrently participating in any clinical trial
  2. Patient who used tolcapone or opicapone previously
  3. For the patient who starts opicapone: concomitant treatment with entacapone or tolcapone is not allowed
  4. Patient with any contraindications to Ongentys use
  5. Patient with any concomitant medical condition that could interfere with study assessments

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site